ADMP has a market capitalization of $45,985,895 -- more than approximately just 13.59% of US stocks.
The volatility of Adamis Pharmaceuticals Corp's share price is greater than that of 88.7% US stocks with at least 200 days of trading history.
Adamis Pharmaceuticals Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -46.28%, greater than the shareholder yield of only 7.99% of stocks in our set.
If you're looking for stocks that are quantitatively similar to Adamis Pharmaceuticals Corp, a group of peers worth examining would be XXII, TUFN, OBLN, CASI, and FLDM.
Adamis Pharmaceuticals Corporation (ADMP) Company Bio
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, engages in developing and commercializing products in the therapeutic areas of allergy and respiratory disease. The company is based in San Diego, California.
Adamis Pharmaceuticals Corporation (ADMP) Q2 2020 Results Conference Call August 20, 2020 04:30 PM ET Company Participants Dr. Dennis Carlo - President and Chief Executive Officer Rob Hopkins - Chief Financial Officer Dr. Ronald Moss - Chief Medical Officer David Marguglio - Chief Business Officer Conference Call Participants Elliot Wilbur...